ASCO GI: Tumor Rate Not Up, Discovery Is
SAN FRANCISCO (MedPage Today) — A high rate of incidentally discovered pancreatic neuroendocrine tumors might explain what appears to be an increasing incidence and improved survival in the disease, investigators reported here.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com